MassBio Annual Meeting 2014

Thursday, April 3 – Friday, April 4 2014

Location: Royal Sonesta Hotel, 40 Edwin Land Blvd, Cambridge, MA


Click  here for full agenda

Online registration is now closed. On-site registration begins Thursday, April 3rd at 8:00am. We look forward to seeing you there!


  • Governor Deval Patrick
  • Senator Elizabeth Warren
  • Margaret Hamburg, Commissioner, Food & Drug Administration
  • Dr. Flemming Ornskov, President & CEO, Shire
  • Dr. George Scangos, CEO, Biogen Idec
  • Brad Margus, CEO, Genome Bridge

Discussions include:

  • Value Cost Effectiveness: Implications of the Changing Landscape in Reimbursement and Regulations
  • Beg, Borrow & Crowdsource? Innovative Ways to Fund Your Early Stage Company          
  • Winning Strategies in Business and Corporate Development
  • The Image Problem of the BioPharma Industry 
  • Clinical Trial Trends
  • Challenges to Managing Big Data   
  • The Second Coming of Molecular Therapies  
  • Mobile Technology and 3D Printing
  • Converging Relationships Between Biotech, Pharma, Investors, and Academia  
  • New Approaches in the Management of Neurological Disease
  • Addressing Opportunity Cost When We Focus on Rare Disease                  

 Don't miss... 

  • The 6th Annual Henri A. Termeer Innovative Leadership Award Luncheon
  • Presentation of the 3rd Annual MassBio Leading Impact Award
  • Annual Joshua Boger Innovative School of the Year Award presented by Takeda
  • Launch of Impact 2020
  • Two networking receptions

We are at a crossroads in the industry—join biotech executives, regulators, entrepreneurs, and funders to hear what the future may hold.



Share MassBio